Rep. Earl L. "Buddy" Carter voted YEA on 100% of eight tracked bills classified as favoring his top donor sectors including Pharmaceuticals & Biotech and Retail & Consumer, ranking #17 among House members on this measure. He voted YEA on HR3537-117, the Accelerating Access to Critical Therapies for ALS Act, classified as favoring Pharmaceuticals & Biotech, and supported 3 of 4 bills classified as limiting those same sectors.

EXAMPLE VOTES BEHIND THE NUMBER
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
S3580-117 — Ocean Shipping Reform Act of 2022
FOLLOW THE TRAIL
◈ Ask the Analyst about Earl L. "Buddy" Carter →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 6, 2026 · internal signal score 90/100.